These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines. Karin N. Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778 [Abstract] [Full Text] [Related]
6. [Novel vaccines against M. tuberculosis]. Okada M. Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [Abstract] [Full Text] [Related]
7. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination. Hermans G, Denzer U, Lohse A, Raus J, Stinissen P. J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392 [Abstract] [Full Text] [Related]
8. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? Shoenfeld Y, Aron-Maor A. J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110 [Abstract] [Full Text] [Related]
9. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M. Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [Abstract] [Full Text] [Related]
10. Antigen-specific therapies in multiple sclerosis. Sospedra M, Martin R. Int Rev Immunol; 2005 Apr; 24(5-6):393-413. PubMed ID: 16318988 [Abstract] [Full Text] [Related]
11. Vaccination with cytokines in autoimmune diseases. Delavallée L, Assier E, Denys A, Falgarone G, Zagury JF, Muller S, Bessis N, Boissier MC. Ann Med; 2008 Apr; 40(5):343-51. PubMed ID: 18484346 [Abstract] [Full Text] [Related]
12. Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines. Karin N. Isr Med Assoc J; 2000 Jul; 2 Suppl():63-8. PubMed ID: 10909420 [Abstract] [Full Text] [Related]
13. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice. Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W. J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048 [Abstract] [Full Text] [Related]
14. T cell vaccination as an immunotherapy for autoimmune diseases. Zhang J. Cell Mol Immunol; 2004 Oct; 1(5):321-7. PubMed ID: 16285890 [Abstract] [Full Text] [Related]
15. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy. Zhang J. Crit Rev Immunol; 2001 Oct; 21(1-3):41-55. PubMed ID: 11642613 [Abstract] [Full Text] [Related]
16. DNA-based vaccines: the future of multiple sclerosis therapy? Stüve O, Cravens PD, Eagar TN. Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967 [Abstract] [Full Text] [Related]
17. Gene vaccination for the induction of immune tolerance. Ferrera F, La Cava A, Rizzi M, Hahn BH, Indiveri F, Filaci G. Ann N Y Acad Sci; 2007 Sep; 1110():99-111. PubMed ID: 17911425 [Abstract] [Full Text] [Related]
18. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [Abstract] [Full Text] [Related]
19. BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis. Correale J, Fiol M. Curr Opin Mol Ther; 2009 Aug; 11(4):463-70. PubMed ID: 19649992 [Abstract] [Full Text] [Related]
20. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Quintana FJ, Carmi P, Mor F, Cohen IR. Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]